talvey
janssen-cilag international n.v. - talquetamab - mieloma múltiplo - agentes antineoplásicos - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
benlysta
glaxosmithkline brasil ltda - belimumabe - imunodepressor
divalproato de sódio
zydus nikkho farmacÊutica ltda - divalproato de sÓdio - anticonvulsivantes
rapamune
laboratÓrios pfizer ltda - sirolimo - agente imunosupressor
apixabana
zydus nikkho farmacÊutica ltda - apixabana - antitrombotico
rapamune
wyeth indÚstria farmacÊutica ltda - agente imunosupressor
rapamune
pfizer brasil ltda - sirolimo - agente imunosupressor
kavium
zydus nikkho farmacÊutica ltda - aripiprazol - antipsicoticos
neoplexus
kley hertz farmaceutica s.a - nitrato de tiamina, cloridrato de piridoxina, cianocobalamina - produtos a base de vit b 12-associacoes medicamentosas
equitam
momenta farmacÊutica ltda. - ginkgo biloba l. - vasodilatadores